Article info
PDFExtended essay
Response
Parsing placebo treatments: a response to Barnhill and Miller
- Correspondence to Dr Shane, Nicholas, Glackin, Egenis, the Centre for the Study of the Life Sciences, University of Exeter, Exeter EX4 4RJ, Devon, UK; shane.n.glackin{at}gmail.com
Citation
Parsing placebo treatments: a response to Barnhill and Miller
Publication history
- Received August 21, 2015
- Revised May 23, 2016
- Accepted May 31, 2016
- First published June 23, 2016.
Online issue publication
September 23, 2016
Article Versions
- Previous version (23 June 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- The ethics of placebo treatments in clinical practice: a reply to Glackin
- Placebo treatments, informed consent and ‘the grip of a false picture’
- Deception, intention and clinical practice
- Ethics of placebo use in clinical practice: why we need to look beyond deontology
- The moral case for the clinical placebo
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials
- Cyclooxygenase 2—implications on maintenance of gastric mucosal integrity and ulcer healing: controversial issues and perspectives
- Pretending to care
- Variability in the Response to Cyclooxygenase Inhibitors
- Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management